Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · IEX Real-Time Price · USD
4.05
+0.03 (0.75%)
Jul 1, 2022 12:26 PM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
|
43.52 | 17.4 | 4.23 | 1.99 | 1.92 | 1.89 | 1.75 | 0.77 | 0 | 0.01 | Upgrade
|
| Revenue Growth (YoY)
|
150.08% | 311.71% | 112.41% | 3.48% | 1.91% | 7.83% | 126.68% | - | - | - | Upgrade
|
| Cost of Revenue
|
4.41 | 2.08 | 2.33 | 0.47 | 0.46 | 0.44 | 0.32 | 0.09 | 0 | 0.01 | Upgrade
|
| Gross Profit
|
39.12 | 15.32 | 1.9 | 1.53 | 1.47 | 1.44 | 1.43 | 0.68 | 0 | 0 | Upgrade
|
| Selling, General & Admin
|
67.07 | 49.47 | 46.61 | 23.73 | 32.51 | 17.71 | 13.02 | 8.9 | 2.39 | 2.13 | Upgrade
|
| Research & Development
|
50.08 | 28.69 | 41.09 | 36.92 | 30.88 | 27.07 | 26.61 | 18.88 | 10.52 | 11.54 | Upgrade
|
| Operating Expenses
|
117.15 | 78.17 | 87.7 | 60.64 | 63.39 | 44.77 | 39.63 | 27.78 | 12.9 | 13.67 | Upgrade
|
| Operating Income
|
-78.04 | -62.85 | -85.8 | -59.12 | -61.92 | -43.33 | -38.2 | -27.09 | -12.9 | -13.67 | Upgrade
|
| Interest Expense / Income
|
6.67 | 6.77 | 6.1 | 1.74 | 1.89 | 1.68 | 1.72 | 1.12 | 0.44 | 0.38 | Upgrade
|
| Other Expense / Income
|
-78.16 | 86.02 | -5.53 | -0.88 | -0.43 | -0.3 | -0.17 | 0.44 | -0.03 | 0.05 | Upgrade
|
| Pretax Income
|
-6.55 | -155.64 | -86.37 | -59.98 | -63.39 | -44.7 | -39.75 | -28.65 | -13.32 | -14.09 | Upgrade
|
| Net Income
|
-6.55 | -155.64 | -86.37 | -59.98 | -63.39 | -44.7 | -39.75 | -28.65 | -13.32 | -14.09 | Upgrade
|
| Preferred Dividends
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0.04 | Upgrade
|
| Net Income Common
|
-6.55 | -155.64 | -86.37 | -59.98 | -63.39 | -44.7 | -39.75 | -28.66 | -13.34 | -14.13 | Upgrade
|
| Shares Outstanding (Basic)
|
76 | 61 | 45 | 38 | 29 | 25 | 23 | 11 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted)
|
82 | 61 | 45 | 38 | 29 | 25 | 23 | 11 | 3 | 3 | Upgrade
|
| Shares Change
|
35.24% | 34.19% | 18.78% | 32.26% | 16.13% | 6.76% | 118.20% | 308.31% | 3.43% | - | Upgrade
|
| EPS (Basic)
|
-0.09 | -2.56 | -1.91 | -1.57 | -2.20 | -1.80 | -1.71 | -2.69 | -5.11 | -5.60 | Upgrade
|
| EPS (Diluted)
|
-0.98 | -2.56 | -1.91 | -1.57 | -2.20 | -1.80 | -1.71 | -2.69 | -5.11 | -5.60 | Upgrade
|
| Free Cash Flow Per Share
|
-0.87 | -0.90 | -1.76 | -1.34 | -2.04 | -1.45 | -1.53 | -2.04 | -5.00 | -5.07 | Upgrade
|
| Gross Margin
|
89.88% | 88.03% | 45.00% | 76.63% | 76.23% | 76.52% | 81.77% | 88.21% | - | 30.00% | Upgrade
|
| Operating Margin
|
-179.31% | -361.13% | -2029.86% | -2970.75% | -3220.13% | -2296.02% | -2182.69% | -3509.59% | - | -100.00% | Upgrade
|
| Profit Margin
|
-15.06% | -894.31% | -2043.34% | -3013.97% | -3296.20% | -2369.00% | -2271.31% | -3712.31% | - | -100.00% | Upgrade
|
| Free Cash Flow Margin
|
-153.36% | -312.56% | -1888.24% | -2568.64% | -3053.56% | -1903.44% | -2029.37% | -2818.13% | - | -100.00% | Upgrade
|
| EBITDA
|
2.54 | -146.1 | -77.74 | -55.95 | -59.87 | -42.14 | -37.27 | -26.98 | -12.47 | -13.31 | Upgrade
|
| EBITDA Margin
|
5.83% | -839.48% | -1839.15% | -2811.71% | -3113.31% | -2233.28% | -2129.71% | -3495.08% | - | -100.00% | Upgrade
|
| Depreciation & Amortization
|
2.42 | 2.77 | 2.53 | 2.29 | 1.63 | 0.88 | 0.75 | 0.55 | 0.4 | 0.4 | Upgrade
|
| EBIT
|
0.12 | -148.87 | -80.27 | -58.24 | -61.49 | -43.02 | -38.02 | -27.53 | -12.88 | -13.72 | Upgrade
|
| EBIT Margin
|
0.27% | -855.42% | -1899.01% | -2926.58% | -3197.82% | -2279.97% | -2172.80% | -3565.93% | - | -100.00% | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).